Emerging Clinical Frontiers: 2026 Vasculitis Market Trends

أضاف وظيفة جديدة Health

2026-01-15 09:18:22 -

As we move through 2026, the management of systemic vasculitis is being redefined by a "biologic-first" philosophy that seeks to replace traditional, high-toxicity immunosuppressants. The clinical community is increasingly moving away from long-term corticosteroid use, which has historically been linked to debilitating side effects like secondary osteoporosis and metabolic dysfunction. This...

0 التعليقات 0 المشاركات 96 مشاهدة 0 معاينة